BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28973132)

  • 1. IKKβ and mutant huntingtin interactions regulate the expression of IL-34: implications for microglial-mediated neurodegeneration in HD.
    Khoshnan A; Sabbaugh A; Calamini B; Marinero SA; Dunn DE; Yoo JH; Ko J; Lo DC; Patterson PH
    Hum Mol Genet; 2017 Nov; 26(21):4267-4277. PubMed ID: 28973132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IKKβ slows Huntington's disease progression in R6/1 mice.
    Ochaba J; Fote G; Kachemov M; Thein S; Yeung SY; Lau AL; Hernandez S; Lim RG; Casale M; Neel MJ; Monuki ES; Reidling J; Housman DE; Thompson LM; Steffan JS
    Proc Natl Acad Sci U S A; 2019 May; 116(22):10952-10961. PubMed ID: 31088970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Huntington's disease pluripotent stem cell-derived microglia develop normally but are abnormally hyper-reactive and release elevated levels of reactive oxygen species.
    O'Regan GC; Farag SH; Casey CS; Wood-Kaczmar A; Pocock JM; Tabrizi SJ; Andre R
    J Neuroinflammation; 2021 Apr; 18(1):94. PubMed ID: 33874957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
    Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
    Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.
    Palazuelos J; Aguado T; Pazos MR; Julien B; Carrasco C; Resel E; Sagredo O; Benito C; Romero J; Azcoitia I; Fernández-Ruiz J; Guzmán M; Galve-Roperh I
    Brain; 2009 Nov; 132(Pt 11):3152-64. PubMed ID: 19805493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the htt
    McAdam RL; Morton A; Gordon SL; Alterman JF; Khvorova A; Cousin MA; Smillie KJ
    Neurobiol Dis; 2020 Feb; 134():104637. PubMed ID: 31614197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock promotes inclusion body formation of mutant huntingtin (mHtt) and alleviates mHtt-induced transcription factor dysfunction.
    Chen JY; Parekh M; Seliman H; Bakshinskaya D; Dai W; Kwan K; Chen KY; Liu AYC
    J Biol Chem; 2018 Oct; 293(40):15581-15593. PubMed ID: 30143534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes.
    Hong Y; Zhao T; Li XJ; Li S
    J Neurosci; 2017 Sep; 37(39):9550-9563. PubMed ID: 28893927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons.
    Kraft AD; Kaltenbach LS; Lo DC; Harry GJ
    Neurobiol Aging; 2012 Mar; 33(3):621.e17-33. PubMed ID: 21482444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced immune response to MMP3 stimulation in microglia expressing mutant huntingtin.
    Connolly C; Magnusson-Lind A; Lu G; Wagner PK; Southwell AL; Hayden MR; Björkqvist M; Leavitt BR
    Neuroscience; 2016 Jun; 325():74-88. PubMed ID: 27033979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.
    Louis Sam Titus ASC; Yusuff T; Cassar M; Thomas E; Kretzschmar D; D'Mello SR
    J Neurosci; 2017 Jul; 37(27):6575-6587. PubMed ID: 28550168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron activates microglia and directly stimulates indoleamine-2,3-dioxygenase activity in the N171-82Q mouse model of Huntington's disease.
    Donley DW; Realing M; Gigley JP; Fox JH
    PLoS One; 2021; 16(5):e0250606. PubMed ID: 33989290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant huntingtin expression in microglia is neither required nor sufficient to cause the Huntington's disease-like phenotype in BACHD mice.
    Petkau TL; Hill A; Connolly C; Lu G; Wagner P; Kosior N; Blanco J; Leavitt BR
    Hum Mol Genet; 2019 May; 28(10):1661-1670. PubMed ID: 30624705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astroglial monoacylglycerol lipase controls mutant huntingtin-induced damage of striatal neurons.
    Ruiz-Calvo A; Bajo-Grañeras R; Maroto IB; Zian D; Grabner GF; García-Taboada E; Resel E; Zechner R; Zimmermann R; Ortega-Gutiérrez S; Galve-Roperh I; Bellocchio L; Guzmán M
    Neuropharmacology; 2019 May; 150():134-144. PubMed ID: 30914306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity.
    Khoshnan A; Ko J; Watkin EE; Paige LA; Reinhart PH; Patterson PH
    J Neurosci; 2004 Sep; 24(37):7999-8008. PubMed ID: 15371500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Exogenous NUB1 Expression in the Striatum of HDQ175/Q7 Mice.
    Vodicka P; Chase K; Iuliano M; Valentine DT; Sapp E; Lu B; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M
    J Huntingtons Dis; 2016 Jun; 5(2):163-74. PubMed ID: 27314618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant huntingtin confers cell-autonomous phenotypes on Huntington's disease iPSC-derived microglia.
    Stöberl N; Donaldson J; Binda CS; McAllister B; Hall-Roberts H; Jones L; Massey TH; Allen ND
    Sci Rep; 2023 Nov; 13(1):20477. PubMed ID: 37993517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity.
    Arango M; Holbert S; Zala D; Brouillet E; Pearson J; Régulier E; Thakur AK; Aebischer P; Wetzel R; Déglon N; Néri C
    J Neurosci; 2006 Apr; 26(17):4649-59. PubMed ID: 16641246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons.
    Rudinskiy N; Kaneko YA; Beesen AA; Gokce O; Régulier E; Déglon N; Luthi-Carter R
    J Neurochem; 2009 Oct; 111(2):460-72. PubMed ID: 19686238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.